Pharma News

BerGenBio has completed (sub.

Roche said a second Phase III study has shown that non-small-cell lung cancer (NSCLC) patients treated with its oral anaplastic lymphoma kinase (ALK) inhibitor Alecensa® (alectini...

PeptiDream has once again turned small molecules into big business, signing a new discovery agreement with Johnson & Johnson’s Janssen Pharmaceutical Companies that could be worth up to $1.

The cystic fibrosis space across the seven major markets of the US, France, Germany, Italy, Spain, the UK, and Canada, is set to more than triple from $2.

The public drama surrounding an investigation into alleged bribes by Novartis to sell more drugs in Greece entered a new act today as the country’s justice minister told a state news agency the drug...

Stada Arzneimittel AG agreed to sell itself to Bain Capital and Cinven for 5.

Jordanian drugmaker Hikma Pharmaceuticals (LSE.

Gilead Sciences hired a former Roche exec last fall to help it launch its hep C and hep B drugs in China, a market with big potential.

New Delhi.

Botox (onabotulinumtoxinA), a treatment which made its name for its aesthetic potential in reducing facial wrinkles, is to be taken into Phase III trials in major depressive disorder (MDD&...

Uruguay's three-year process of legalizing recreational cannabis consumption reached its final stage on Thursday, when the government said it would authorize pharmacies to begin selling the substa...

MUMBAI, India — Cipla received Food and Drug Administration approval for its Abbreviated New Drug Application for Abacavir and Lamivudine Tablets USP, 600 mg/300 mg, from the Abacavir and Lamivudine...